Comparative efficacy of biologics in psoriasis: a review.
about
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabThe pathophysiological role of dendritic cell subsets in psoriasis.Retinal upregulation of inflammatory and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet.Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patientsAnnual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Systemic therapies for psoriasis: an evidence-based update.Apremilast for the treatment of psoriatic arthritis.Pharmacological therapy of spondyloarthritis.The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.A Real-World Study to Assess the Effectiveness of Itolizumab in Patients with Chronic Plaque Psoriasis.Control of late cornified envelope genes relevant to psoriasis risk: upregulation by 1,25-dihydroxyvitamin D3 and plant-derived delphinidin.Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden.Objective measurement of erythema in psoriasis using digital color photography with color calibration.Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents.The Goeckerman regimen for the treatment of moderate to severe psoriasis.Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis.Efficacy and safety of ustekinumab in adolescents.
P2860
Q33573621-7690951B-24C6-4079-BA61-2C1401EFAB6BQ34180103-01BEB894-40CF-4C9D-86F7-17911076B799Q34669369-FEA00045-28BD-4B21-9A85-5058C2D414C3Q34894016-DD10B0F9-3BB0-4D04-B101-D44873D04031Q34944668-54873727-E831-4BFD-8C0D-908552DB4660Q37295966-97E323B7-3941-48A0-ADEB-FC43BF1FEB39Q38185297-976C4EB4-DAF0-4209-976C-324025F2CB4FQ38202205-3D321AF3-0F7A-476A-AAD5-905F94F5FE07Q38527552-B95D74C1-B847-4D72-A40E-7EC6BD090E02Q38612964-8BB26774-D8EB-4827-9DF8-512E67295AB6Q38650265-BBA96337-6A34-4546-B009-B02DA65B5D54Q39128243-6FA138BD-C886-43D8-927E-2494DD2EA5B5Q40218228-A66FC388-FF9F-492D-976B-B5494BFD9711Q40326400-5CC70357-7E74-4A7A-ABBA-4D7C4DD3F546Q41684920-4976AE8A-9001-4A57-A17D-007F09D1A388Q41919734-0D440D32-CD4B-4966-84F8-38D4B2BC73D0Q42540506-8BA938E3-7631-4382-AFE1-CD0DC28BC209Q48104675-38AC1649-213B-45DA-801F-A0EBE3B23D88Q49500789-DC4DF23F-C5CA-4430-9A68-BF4C54BB5FF6
P2860
Comparative efficacy of biologics in psoriasis: a review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Comparative efficacy of biologics in psoriasis: a review.
@en
type
label
Comparative efficacy of biologics in psoriasis: a review.
@en
prefLabel
Comparative efficacy of biologics in psoriasis: a review.
@en
P2093
P2860
P1476
Comparative efficacy of biologics in psoriasis: a review
@en
P2093
Cameron E West
Iris H Kim
Jenna L O'Neill
Shawn G Kwatra
P2860
P304
P356
10.2165/11633110-000000000-00000
P577
2012-12-01T00:00:00Z
P6179
1011699660